Skip to Content


Manufacturer of Controlled Substances; Notice of Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated June 23, 2011, and published in the Federal Register on July 5, 2011, 76 FR 39126, Chemtos, LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Amphetamine (1100)II
Methamphetamine (1105)II
Lisdexamfetamine (1205)II
Methylphenidate (1724)II
Nabilone (7379)II
Phenylacetone (8501)II
Cocaine (9041)II
Codeine (9050)II
Etorphine HCL (9059)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Ecgonine (9180)II
Ethylmorphine (9190)II
Hydrocodone (9193)II
Levomethorphan (9210)II
Levorphanol (9220)II
Isomethadone (9226)II
Meperidine (9230)II
Meperidine-intermediate-A (9232)II
Meperidine-intermediate-B (9233)II
Meperidine-intermediate-C (9234)II
Methadone (9250)II
Methadone intermediate (9254)II
Morphine (9300)II
Thebaine (9333)II
Dihydroetorphine (9334)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II
Racemethorphan (9732)II
Racemorphan (9733)II

The company plans to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers for use as reference standards.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chemtos, LLC, to manufacture the listed basic classes of controlled substances is consistent with the public interest at Start Printed Page 73680this time. DEA has investigated Chemtos, LLC, to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Start Signature

Dated: November 21, 2011.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2011-30690 Filed 11-28-11; 8:45 am]